publication venue for
- Genetic and phenotypic characterization of Parkinson's disease at the clinic-wide level.. 10:-. 2024
- Care access and utilization among medicare beneficiaries living with Parkinson's disease.. 9:-. 2023
- Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein.. 8:-. 2022
- Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson's disease enrolled in PPMI.. 7:-. 2021
- State-level prevalence, health service use, and spending vary widely among Medicare beneficiaries with Parkinson disease.. -. 2019
- Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health.. -. 2018